3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
4
Ureteral Neoplasms
3
Urologic Neoplasms
2
Urethral Neoplasms
2
Carcinoma, Transitional Cell
2
Urothelial Cancer
1
Metastatic Urothelial Cancer
1
Interventions
Cetuximab
5
Bevacizumab
4
pembrolizumab
3
Leucovorin
3
Irinotecan
3
Fluorouracil
3
trifluridine tipiracil drug combination
2
trastuzumab deruxtecan
2
larotrectinib
2
encorafenib
2
binimetinib
2
Trastuzumab
2
Oxaliplatin
2
Nivolumab
2
HMPL-013
2
Afatinib
2
ulixertinib
1
tucatinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sotorasib
1
sapanisertib
1
relatlimab
1
regorafenib
1
pralsetinib
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
ipatasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Colorectal Neoplasms
×
enfortumab vedotin
×
Clear all
No trials found.